Zhejiang Huahai Pharmaceutical Co Ltd Total Assets
Zhejiang Huahai Pharmaceutical Co Ltd total assets. Based on the latest financial reports, Zhejiang Huahai Pharmaceutical Co Ltd (600521) holds total assets worth CN¥21.95 Billion CNY (≈ $3.21 Billion USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see 600521 operating cash flow for how efficiently the company converts equity into cash flow.
Total Assets of Zhejiang Huahai Pharmaceutical Co Ltd (2000–2025)
Total assets of Zhejiang Huahai Pharmaceutical Co Ltd from 2000 to 2025. This chart illustrates how Zhejiang Huahai Pharmaceutical Co Ltd's total assets have evolved over time, based on quarterly financial data. See 600521 stock price and chart for real-time trading data and today's change.
Zhejiang Huahai Pharmaceutical Co Ltd - Asset Composition Analysis
Zhejiang Huahai Pharmaceutical Co Ltd Total Assets Breakdown (December 2025)
Zhejiang Huahai Pharmaceutical Co Ltd total assets breakdown as of December 2025. Zhejiang Huahai Pharmaceutical Co Ltd's total assets of CN¥21.95 Billion consist of 40.7% current assets and 59.3% non-current assets. Explore how liquid is Zhejiang Huahai Pharmaceutical Co Ltd's working capital to assess how much short-term liquidity the company maintains relative to its equity base.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 7.0% |
| Accounts Receivable | CN¥2.87 Billion | 13.3% |
| Inventory | CN¥3.71 Billion | 17.3% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥2.22 Billion | 10.3% |
| Goodwill | CN¥64.45 Million | 0.3% |
Asset Composition Trend (2000–2025)
This chart illustrates how Zhejiang Huahai Pharmaceutical Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Zhejiang Huahai Pharmaceutical Co Ltd's current assets represent 40.7% of total assets in 2025, a decrease from 68.0% in 2000.
- Cash Position: Cash and equivalents constituted 7.0% of total assets in 2025, down from 35.3% in 2000.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 10.0% of total assets, an increase from 2.0% in 2000.
- Asset Diversification: The largest asset category is inventory at 17.3% of total assets.
Zhejiang Huahai Pharmaceutical Co Ltd Competitors by Total Assets
Key competitors of Zhejiang Huahai Pharmaceutical Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
GALDERMA GROUP AG
NYSE:GALDY
|
USA | $13.39 Billion |
|
Takeda Pharmaceutical Company Limited
F:TKDA
|
Germany | €15.41 Trillion |
|
Galderma Group N
SW:GALD
|
Switzerland | CHF12.88 Billion |
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
|
Germany | €1.60 Trillion |
|
Ajanta Pharma Limited
NSE:AJANTPHARM
|
India | Rs56.72 Billion |
|
Changchun High & New Technology Industries Group Inc
SHE:000661
|
China | CN¥30.77 Billion |
|
Chengdu Kanghong Pharmaceuticals Group Co Ltd
SHE:002773
|
China | CN¥9.94 Billion |
|
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858
|
China | CN¥19.57 Billion |
Zhejiang Huahai Pharmaceutical Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.05 | 1.56 | 1.90 |
| Quick Ratio | 0.63 | 0.93 | 1.15 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥406.61 Million | CN¥3.20 Billion | CN¥3.23 Billion |
Zhejiang Huahai Pharmaceutical Co Ltd - Advanced Valuation Insights
This section examines the relationship between Zhejiang Huahai Pharmaceutical Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.35 |
| Latest Market Cap to Assets Ratio | 0.17 |
| Asset Growth Rate (YoY) | 6.1% |
| Total Assets | CN¥21.50 Billion |
| Market Capitalization | $3.67 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Zhejiang Huahai Pharmaceutical Co Ltd's assets below their book value (0.17x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Zhejiang Huahai Pharmaceutical Co Ltd's assets grew by 6.1% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Zhejiang Huahai Pharmaceutical Co Ltd (2000–2025)
The table below shows the annual total assets of Zhejiang Huahai Pharmaceutical Co Ltd from 2000 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥21.50 Billion ≈ $3.15 Billion |
+6.13% |
| 2024-12-31 | CN¥20.26 Billion ≈ $2.96 Billion |
+8.93% |
| 2023-12-31 | CN¥18.60 Billion ≈ $2.72 Billion |
+2.47% |
| 2022-12-31 | CN¥18.15 Billion ≈ $2.66 Billion |
+17.35% |
| 2021-12-31 | CN¥15.47 Billion ≈ $2.26 Billion |
+19.07% |
| 2020-12-31 | CN¥12.99 Billion ≈ $1.90 Billion |
+21.08% |
| 2019-12-31 | CN¥10.73 Billion ≈ $1.57 Billion |
+3.49% |
| 2018-12-31 | CN¥10.37 Billion ≈ $1.52 Billion |
+25.41% |
| 2017-12-31 | CN¥8.27 Billion ≈ $1.21 Billion |
+22.90% |
| 2016-12-31 | CN¥6.73 Billion ≈ $984.28 Million |
+21.95% |
| 2015-12-31 | CN¥5.52 Billion ≈ $807.09 Million |
+22.29% |
| 2014-12-31 | CN¥4.51 Billion ≈ $659.96 Million |
+0.98% |
| 2013-12-31 | CN¥4.47 Billion ≈ $653.53 Million |
+38.84% |
| 2012-12-31 | CN¥3.22 Billion ≈ $470.69 Million |
+24.82% |
| 2011-12-31 | CN¥2.58 Billion ≈ $377.10 Million |
+25.45% |
| 2010-12-31 | CN¥2.05 Billion ≈ $300.60 Million |
+18.38% |
| 2009-12-31 | CN¥1.74 Billion ≈ $253.92 Million |
+14.34% |
| 2008-12-31 | CN¥1.52 Billion ≈ $222.07 Million |
+20.13% |
| 2007-12-31 | CN¥1.26 Billion ≈ $184.86 Million |
+15.05% |
| 2006-12-31 | CN¥1.10 Billion ≈ $160.68 Million |
+12.62% |
| 2005-12-31 | CN¥975.04 Million ≈ $142.68 Million |
+8.88% |
| 2004-12-31 | CN¥895.55 Million ≈ $131.05 Million |
+15.60% |
| 2003-12-31 | CN¥774.68 Million ≈ $113.36 Million |
+212.14% |
| 2002-12-31 | CN¥248.18 Million ≈ $36.32 Million |
+10.86% |
| 2001-12-31 | CN¥223.88 Million ≈ $32.76 Million |
+25.76% |
| 2000-12-31 | CN¥178.02 Million ≈ $26.05 Million |
-- |
About Zhejiang Huahai Pharmaceutical Co Ltd
Zhejiang Huahai Pharmaceutical Co., Ltd. engaged in the research, development, production, and sales of generic drugs, biologics, drugs, and specialty active pharmaceutical ingredients in multiple dosage forms in China and internationally. The company offers central neurological, cardiovascular, anti-viral, and other products, as well as APIs and intermediates. It also provides packaging componen… Read more